Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
Massachusetts General Hospital
Massachusetts General Hospital
University of Utah
University of Alcala
Saint-Gregoire Private Hospital Center
University of Seville
Fondation Hôpital Saint-Joseph
University of Missouri, Kansas City
National Cancer Institute, Egypt
King's College London
University Rovira i Virgili
Chang Gung Memorial Hospital
Cedars-Sinai Medical Center
Ciusss de L'Est de l'Île de Montréal
University Hospital, Clermont-Ferrand
Mersin University
Uludag University
Akdeniz University
Ege University
Assistance Publique - Hôpitaux de Paris
Rigshospitalet, Denmark
The Second Affiliated Hospital of Chongqing Medical University
National Cancer Institute, Naples
National Cancer Institute, Naples
The Methodist Hospital Research Institute
Peking University People's Hospital
University of Aarhus
The Second Affiliated Hospital of Chongqing Medical University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Uskudar University
University of Aarhus
The Hong Kong Polytechnic University
Tel-Aviv Sourasky Medical Center
University of Cyprus
Shanghai Pulmonary Hospital, Shanghai, China
Institut Cancerologie de l'Ouest
Central Hospital, Nancy, France
Canisius-Wilhelmina Hospital
Sheffield Teaching Hospitals NHS Foundation Trust
Poitiers University Hospital
Hospital Universitario La Paz
Fondazione ANT Italia ONLUS
Poissy-Saint Germain Hospital
Yonsei University
Show Chwan Memorial Hospital
Antea Foundation
The Hong Kong Polytechnic University
Democritus University of Thrace
The University of Hong Kong
Riverview Health Centre
University of Copenhagen